PAX3

Paired box protein Pax-3 (HuP2) · P23760 · PAX3 on Sugi Atlas →

119 patent compounds predicted against PAX3, 23 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL31661274 SCHEMBL31661274 0.51 4/20
SCHEMBL31661281 SCHEMBL31661281 0.52 3/20
SCHEMBL25324519 SCHEMBL25324519 0.46 2/20
SCHEMBL11703118 SCHEMBL11703118 0.50 1/20
SCHEMBL11703130 SCHEMBL11703130 0.50 1/20
SCHEMBL17283462 SCHEMBL17283462 0.47 1/20
SCHEMBL9728432 SCHEMBL9728432 0.46 1/20
SCHEMBL1425017 SCHEMBL1425017 0.46 1/20
SCHEMBL4405834 SCHEMBL4405834 0.46 1/20
SCHEMBL9728547 SCHEMBL9728547 0.46 1/20
SCHEMBL28251697 SCHEMBL28251697 0.46 1/20
SCHEMBL9154861 SCHEMBL9154861 0.46 1/20
SCHEMBL13872774 SCHEMBL13872774 0.46 1/20
SCHEMBL29283546 SCHEMBL29283546 0.46 1/20
SCHEMBL12375884 SCHEMBL12375884 0.45 1/20
SCHEMBL26857602 SCHEMBL26857602 0.45 1/20
SCHEMBL11102577 SCHEMBL11102577 0.44 1/20
SCHEMBL5385642 SCHEMBL5385642 0.44 1/20
SCHEMBL18104410 SCHEMBL18104410 0.43 1/20
SCHEMBL7393964 SCHEMBL7393964 0.43 1/20

Clinical trials — most relevant to PAX3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma PHASE3ACTIVE_NOT_RECRUITING
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma PHASE1/PHASE2RECRUITING
Evolutionary Therapy for Rhabdomyosarcoma PHASE2ACTIVE_NOT_RECRUITING
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 PHASE1/PHASE2COMPLETED
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma PHASE1RECRUITING
Biomarkers in Patients With Advanced Rhabdomyosarcoma nanCOMPLETED
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma nanCOMPLETED
Cervical Cytology DNA Methylation for Cervical Cancer Screening nanNOT_YET_RECRUITING
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma nanCOMPLETED
The Role of TBX3 in Human ES Cell Differentiation nanWITHDRAWN
Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients nanUNKNOWN
The Role of CSF in Chiari II Brain Malformation nanNOT_YET_RECRUITING
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Chordoma Family Study nanCOMPLETED
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia nanUNKNOWN
Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes nanACTIVE_NOT_RECRUITING
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma nanCOMPLETED
Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction nanCOMPLETED
Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families nanCOMPLETED
Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique nanCOMPLETED
Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors nanCOMPLETED
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study nanCOMPLETED
DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma nanCOMPLETED
RORC Genetic Polymorphism of Rheumatoid Arthritis nanCOMPLETED
Congenital Aniridia Patient Questionnaire nanRECRUITING
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science nanRECRUITING
Role of HIF-1α in Skeletal Muscle Aging nanUNKNOWN
3D-Microscopic Muscle Architecture in Cerebral Palsy nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PAX3 binder may also engage these)

ProteinNameSimilarity
P24610 1.000 P24610 →
P47239 1.000 P47239 →
Q645N4 1.000 Q645N4 →
Q0IH87 1.000 Q0IH87 →
P23759 1.000 P23759 →
Q1LZF1 1.000 Q1LZF1 →
P47238 1.000 P47238 →
G5EDS1 1.000 G5EDS1 →
P55864 1.000 P55864 →
Q812B1 1.000 Q812B1 →
P47240 1.000 P47240 →
P32114 0.999 P32114 →
Q90268 0.999 Q90268 →
PAX2 Paired box protein Pax-2 0.999 landscape →
Q9PVY9 0.999 Q9PVY9 →
P35680 0.999 P35680 →
PAX8 Paired box protein Pax-8 0.999 landscape →
P27889 0.999 P27889 →
Q03365 0.998 Q03365 →
Q98876 0.998 Q98876 →
P31363 0.998 P31363 →
O93529 0.998 O93529 →
Q91904 0.998 Q91904 →
Q22510 0.998 Q22510 →
P57682 0.998 P57682 →
P47242 0.998 P47242 →
O73917 0.998 O73917 →
P40645 0.997 P40645 →
Q90867 0.997 Q90867 →
B7ZQA9 0.997 B7ZQA9 →